Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer

Fig. 1

Survival of different treatment sequences. Legends: Kaplan-Meier curves of patients who were treated with one of the three treatment sequences from first to second and third line: A line, 37 patients, refers to NabP/Gem or NabP combined therapy to FOLFIRINOX (red line), B line, 37 patients, refers to NabP combined therapy to Gem combined therapy to FOLFIRINOX (green line) and C line, 21 patients, refers to NabP combined therapy to Gem combined therapy to oxaliplatin or irinotecan combined therapy (purple line)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us